Permanent transvenous pacing can lead to thrombotic obstruction of the superior vena cava, which was successfully treated with anticoagulants with no symptoms at 36 months.
Anticoagulant therapy can successfully treat superior vena cava syndrome resulting from transvenous pacemaker-induced thrombosis.
Absolute Event Rate: 0% vs 0%
A complication of permanent transvenous pacing leading to thrombotic obstruction of the superior vena cava and left brachiocephalic vein is reported. Symptoms of the superior vena cava syndrome were successfully treated with anticoagulants. The patient has no symptoms of venous obstruction 36 months after the complication.
Gundersen et al. (Tue,) reported a other. Permanent transvenous pacing can lead to thrombotic obstruction of the superior vena cava, which was successfully treated with anticoagulants with no symptoms at 36 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: